<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="c051e90e-95f3-42a4-8271-ff1f492e3266"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Care-plan review) — Gwen Ifill</title>
  <effectiveTime value="20260630120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="887fc387-ec74-4d4a-85bd-af586d6a3c62"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="b2dcde60-345c-46e2-adb6-1cee7d8b4f74" extension="HR-ML032-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-32-5814"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Gwen</given><family>Ifill</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19650929"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260630120000-0500"/>
    <assignedAuthor><id root="65a6e1dc-89af-442a-bade-415b3ef897e1"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Lorna</given><family>Achebe-Price</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260630120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="65a6e1dc-89af-442a-bade-415b3ef897e1"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Lorna</given><family>Achebe-Price</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260630"/><high value="20260630"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="65a6e1dc-89af-442a-bade-415b3ef897e1"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Lorna</given><family>Achebe-Price</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="8eb49eee-b390-4b5b-9efa-db328f81f5ac"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>End of combination treatment: response CT, immune-related hypothyroidism, the first maintenance dostarlimab dose, and the survivorship plan</originalText></code>
      <effectiveTime><low value="20260630"/><high value="20260630"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="65a6e1dc-89af-442a-bade-415b3ef897e1"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Lorna</given><family>Achebe-Price</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>End of combination treatment: CT result, thyroid tests, and the first maintenance dose. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Ifill returns three weeks after her sixth and last cycle of combination treatment, all given on schedule. The CT a week ago shows no evidence of disease. Over the past month she has felt more tired than after earlier cycles, colder than usual, and a little slowed down, without low mood. The tingling in her toes is unchanged and does not affect walking. She has had no vaginal bleeding, pelvic pain, cough, breathlessness, diarrhea, rash, headache, dizziness or leg swelling. She saw Dr. Delacroix with the CT result and is ready to begin maintenance dostarlimab today. She has had no thoughts of self-harm. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Treatment</td><td>Six cycles of dostarlimab, carboplatin and paclitaxel completed on schedule</td></tr><tr><td>Response</td><td>CT: no evidence of disease</td></tr><tr><td>New symptoms</td><td>Tiredness and feeling cold for a month</td></tr><tr><td>Neuropathy</td><td>Grade 1, unchanged</td></tr><tr><td>Today</td><td>First maintenance dose of dostarlimab 1000 mg</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Positive</td><td>Tired and feels cold; no fever or weight loss</td></tr><tr><td>Genitourinary</td><td>Negative</td><td>No vaginal bleeding or discharge</td></tr><tr><td>Gastrointestinal</td><td>Negative</td><td>No diarrhea, constipation or abdominal pain</td></tr><tr><td>Respiratory</td><td>Negative</td><td>No cough or breathlessness</td></tr><tr><td>Neurological</td><td>Positive</td><td>Tingling in the toes, unchanged; no headache or dizziness</td></tr><tr><td>Endocrine</td><td>Positive</td><td>Cold intolerance; no thirst</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood good; PHQ-9 4; no thoughts of self-harm</td></tr></tbody></table><paragraph>7 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a day</td><td>Two tablets every 6 hours as needed</td><td>Oral route</td><td>2026-02-03 to 2026-02-17</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Dostarlimab 50 mg/mL injection, 500 mg intravenously over 30 minutes on day 1 of each 21-day cycle, before carboplatin and paclitaxel, for six cycles</td><td>Day 1 every 21 days for six cycles</td><td>Intravenous route</td><td>2026-02-24 to 2026-06-09</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Carboplatin 10 mg/mL injection, 575 mg (AUC 5) intravenously on day 1 of each 21-day cycle, for six cycles</td><td>Day 1 every 21 days for six cycles</td><td>Intravenous route</td><td>2026-02-24 to 2026-06-09</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Paclitaxel 6 mg/mL injection, 320 mg (175 mg/m2) intravenously over 3 hours on day 1 of each 21-day cycle, for six cycles, after dexamethasone, diphenhydramine and famotidine</td><td>Day 1 every 21 days for six cycles</td><td>Intravenous route</td><td>2026-02-24 to 2026-06-09</td><td>completed</td><td>S</td></tr><tr ID="medication-5"><td>Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea</td><td>One tablet every 8 hours as needed for nausea</td><td>Oral route</td><td>2026-02-24 to 2026-06-30</td><td>completed</td><td>S</td></tr><tr ID="medication-6"><td>Dostarlimab 50 mg/mL injection, 1000 mg intravenously over 30 minutes every 6 weeks as maintenance, for up to three years</td><td>Every 6 weeks</td><td>Intravenous route</td><td>2026-06-30</td><td>active</td><td>S</td></tr><tr ID="medication-7"><td>Levothyroxine 75 mcg oral tablet, one tablet daily before breakfast</td><td>One tablet daily before breakfast</td><td>Oral route</td><td>2026-06-30</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="83594145-b2b7-475c-8a32-66523ff7ff60"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260203"/><high value="20260217"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="67d479aa-3740-4f59-9cf1-3827eba9bda5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="9d3a5b71-00a8-4b90-94d8-05f23c7cb4e1"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260224"/><high value="20260609"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="21" unit="d"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="500" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2539972" codeSystem="2.16.840.1.113883.6.88" displayName="10 ML dostarlimab-gxly 50 MG/ML Injection"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="59ba6e1d-6b4b-46f9-a0f1-d815338abdbb"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="a1326237-7bd1-41a7-8b2d-66469a571331"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="04d491e5-f059-4375-832b-95a0604a9547"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260224"/><high value="20260609"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="21" unit="d"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="575" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="597195" codeSystem="2.16.840.1.113883.6.88" displayName="carboplatin 10 MG/ML Injectable Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="22b03f15-8910-4e18-a882-7a6642cc8803"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6d9bd01f-c76c-46d2-8835-4adb9ff36654"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="287401b0-74fa-4cde-b764-eea00a00b92d"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260224"/><high value="20260609"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="21" unit="d"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="320" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="312199" codeSystem="2.16.840.1.113883.6.88" displayName="paclitaxel 6 MG/ML Injectable Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6d978dca-7bec-4f67-8904-907322210f1d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="3e7983a7-43da-4a31-95cc-f61ecee094ab"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="5d1f83ce-a5ca-4a8f-8986-199e14166ab4"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260224"/><high value="20260630"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="312086" codeSystem="2.16.840.1.113883.6.88" displayName="ondansetron 8 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f1561978-30d9-4663-bd5c-da18417a023c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="12f607d6-c031-443d-8ca8-1a17e62db507"/>
      <text><reference value="#medication-6"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260630"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="wk"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="1000" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2539972" codeSystem="2.16.840.1.113883.6.88" displayName="10 ML dostarlimab-gxly 50 MG/ML Injection"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="4f85814c-e80d-49d3-9ee4-cfc197381fa3"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f23b834b-2c72-4170-b4ca-0b3c06f22ffd"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="61f90326-f1dc-4721-8558-10bd991a0958"/>
      <text><reference value="#medication-7"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260630"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="966222" codeSystem="2.16.840.1.113883.6.88" displayName="levothyroxine sodium 0.075 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="53bf2b12-2581-4ea0-b8ee-dd6893d1ebb9"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E03.2" codeSystem="2.16.840.1.113883.6.90" displayName="Hypothyroidism due to medicaments and other exogenous substances"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="62a13adb-79b6-4818-89a7-5d5351b98bd7"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260105"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="4c1431c9-5a66-421e-b409-53512b4308d7"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-5-1"><td>2026-06-30</td><td>Body height</td><td>165</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-5-2"><td>2026-06-30</td><td>Body weight</td><td>72.4</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-5-3"><td>2026-06-30</td><td>Body mass index (BMI) [Ratio]</td><td>26.6</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-5-4"><td>2026-06-30</td><td>Systolic blood pressure</td><td>122</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-5-5"><td>2026-06-30</td><td>Diastolic blood pressure</td><td>78</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-5-6"><td>2026-06-30</td><td>Heart rate</td><td>64</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-5-7"><td>2026-06-30</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-5-8"><td>2026-06-30</td><td>Body temperature</td><td>36.4</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-5-9"><td>2026-06-30</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>98</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="453a980e-4248-4a17-9772-9507303be545"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260630"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="71cd3406-d9b5-4fa5-ac87-aaec4a2fb77a"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-5-1"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="165" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="46ea87f8-e788-4c23-a01f-5afbf3a3f907"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-5-2"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="72.4" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="14fb833b-a70f-42d5-95c2-df5a1774bc89"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-5-3"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="26.6" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="dc3c2d98-9d1b-4e8c-9702-96d98156583b"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-5-4"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="122" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="910e148b-e3d3-4879-a71f-abdcbdc970fa"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-5-5"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="78" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="816a8036-8218-47e7-84c4-f65f10023748"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-5-6"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="64" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="21b958ae-666c-43d2-b1fd-c71069be4608"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-5-7"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5f2d6871-7a62-4b15-a05e-4e01fe6b130a"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-5-8"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="36.4" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="0815a66e-15b2-4120-b6c0-a25f8749e794"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-5-9"/></text><statusCode code="completed"/><effectiveTime value="20260630"/><value xsi:type="PQ" value="98" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-54"><td>2026-06-30</td><td>Hemoglobin [Mass/volume] in Blood</td><td>11.4</td><td>g/dL</td><td>12-15.5 g/dL</td><td>Low</td><td>S</td></tr>
  <tr ID="result-55"><td>2026-06-30</td><td>Leukocytes [#/volume] in Blood by Automated count</td><td>4.9</td><td>10*3/uL</td><td>4-11 10*3/uL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-56"><td>2026-06-30</td><td>Neutrophils [#/volume] in Blood by Automated count</td><td>2.8</td><td>10*3/uL</td><td>1.5-7.7 10*3/uL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-57"><td>2026-06-30</td><td>Platelets [#/volume] in Blood by Automated count</td><td>228</td><td>10*3/uL</td><td>150-400 10*3/uL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-58"><td>2026-06-30</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>0.84</td><td>mg/dL</td><td>0.59-1.04 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-59"><td>2026-06-30</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M</td><td>80</td><td>mL/min/{1.73_m2}</td><td>&gt;=60 mL/min/1.73 m²</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-60"><td>2026-06-30</td><td>Glucose [Mass/volume] in Serum or Plasma</td><td>90</td><td>mg/dL</td><td>70-99 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-61"><td>2026-06-30</td><td>Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>22</td><td>U/L</td><td>7-35 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-62"><td>2026-06-30</td><td>Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>24</td><td>U/L</td><td>8-35 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-63"><td>2026-06-30</td><td>Bilirubin.total [Mass/volume] in Serum or Plasma</td><td>0.5</td><td>mg/dL</td><td>0.1-1.2 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-64"><td>2026-06-30</td><td>Thyrotropin [Units/volume] in Serum or Plasma</td><td>11.8</td><td>m[IU]/L</td><td>0.4-4.5 mIU/L</td><td>High</td><td>S</td></tr>
  <tr ID="result-65"><td>2026-06-30</td><td>Thyroxine (T4) free [Mass/volume] in Serum or Plasma</td><td>0.7</td><td>ng/dL</td><td>0.8-1.8 ng/dL</td><td>Low</td><td>S</td></tr>
  <tr ID="result-66"><td>2026-06-30</td><td>Cortisol [Mass/volume] in Serum or Plasma</td><td>13.1</td><td>ug/dL</td><td>Morning sample, drawn before 9 a.m.</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-67"><td>2026-06-30</td><td>Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]</td><td>4</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3cd21b54-fc22-4b71-8148-6f07ff1d2145"/>
      <code code="58410-2" codeSystem="2.16.840.1.113883.6.1" displayName="CBC panel - Blood by Automated count"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260630"/><high value="20260630"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="2f7ef6cd-6e7a-48bb-b322-c7e2b2eb1d17"/>
          <code code="718-7" codeSystem="2.16.840.1.113883.6.1" displayName="Hemoglobin [Mass/volume] in Blood"/>
          <text><reference value="#result-54"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="11.4" unit="g/dL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>12-15.5 g/dL</text>
              <value xsi:type="IVL_PQ"><low value="12" unit="g/dL"/><high value="15.5" unit="g/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="595498eb-1460-42ad-9449-76bb49735824"/>
          <code code="6690-2" codeSystem="2.16.840.1.113883.6.1" displayName="Leukocytes [#/volume] in Blood by Automated count"/>
          <text><reference value="#result-55"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="4.9" unit="10*3/uL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>4-11 10*3/uL</text>
              <value xsi:type="IVL_PQ"><low value="4" unit="10*3/uL"/><high value="11" unit="10*3/uL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="d9ce1073-aea2-4368-b12c-ad5663e4ef59"/>
          <code code="751-8" codeSystem="2.16.840.1.113883.6.1" displayName="Neutrophils [#/volume] in Blood by Automated count"/>
          <text><reference value="#result-56"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="2.8" unit="10*3/uL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>1.5-7.7 10*3/uL</text>
              <value xsi:type="IVL_PQ"><low value="1.5" unit="10*3/uL"/><high value="7.7" unit="10*3/uL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="321b2488-1360-40b2-928f-6cfa9ed63457"/>
          <code code="777-3" codeSystem="2.16.840.1.113883.6.1" displayName="Platelets [#/volume] in Blood by Automated count"/>
          <text><reference value="#result-57"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="228" unit="10*3/uL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>150-400 10*3/uL</text>
              <value xsi:type="IVL_PQ"><low value="150" unit="10*3/uL"/><high value="400" unit="10*3/uL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3a5d1730-5af4-4efe-8370-66a0d1600fb6"/>
      <code code="24323-8" codeSystem="2.16.840.1.113883.6.1" displayName="Comprehensive metabolic 2000 panel - Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260630"/><high value="20260630"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="5b21dd28-e9f6-4cf5-930f-7c477b11ba9d"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-58"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="0.84" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.59-1.04 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.59" unit="mg/dL"/><high value="1.04" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="ba7ec7b8-6812-4a84-adf5-e683a904828a"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-59"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="80" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&gt;=60 mL/min/1.73 m²</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="14adc398-6176-4813-a275-3196d77babff"/>
          <code code="2345-7" codeSystem="2.16.840.1.113883.6.1" displayName="Glucose [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-60"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="90" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>70-99 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="70" unit="mg/dL"/><high value="99" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="dddccfef-2b5a-467e-bfb1-17c4ae5dbf23"/>
          <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-61"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="22" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>7-35 U/L</text>
              <value xsi:type="IVL_PQ"><low value="7" unit="U/L"/><high value="35" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="34fe01cc-9766-45db-bd9a-5a37186434e5"/>
          <code code="1920-8" codeSystem="2.16.840.1.113883.6.1" displayName="Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-62"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="24" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>8-35 U/L</text>
              <value xsi:type="IVL_PQ"><low value="8" unit="U/L"/><high value="35" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="2661abc5-3e12-433d-a18c-4c3a462da693"/>
          <code code="1975-2" codeSystem="2.16.840.1.113883.6.1" displayName="Bilirubin.total [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-63"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="0.5" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.1-1.2 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.1" unit="mg/dL"/><high value="1.2" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="28e20039-81b3-427a-85f8-8d18abf2d75b"/>
      <code code="3016-3" codeSystem="2.16.840.1.113883.6.1" displayName="Thyrotropin [Units/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260630"/><high value="20260630"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="2d98959c-7283-4d61-abdf-9e3d63fdd25c"/>
          <code code="3016-3" codeSystem="2.16.840.1.113883.6.1" displayName="Thyrotropin [Units/volume] in Serum or Plasma"/>
          <text><reference value="#result-64"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="11.8" unit="m[IU]/L"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>0.4-4.5 mIU/L</text>
              <value xsi:type="IVL_PQ"><low value="0.4" unit="m[IU]/L"/><high value="4.5" unit="m[IU]/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="580c9524-118a-4619-9611-3755c154d1a2"/>
      <code code="3024-7" codeSystem="2.16.840.1.113883.6.1" displayName="Thyroxine (T4) free [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260630"/><high value="20260630"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="083fb35e-743f-4fb2-9014-50d5474d37a9"/>
          <code code="3024-7" codeSystem="2.16.840.1.113883.6.1" displayName="Thyroxine (T4) free [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-65"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="0.7" unit="ng/dL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>0.8-1.8 ng/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.8" unit="ng/dL"/><high value="1.8" unit="ng/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="1aa4f302-fdcb-43c0-b7e0-7b6d7a4f91f7"/>
      <code code="2143-6" codeSystem="2.16.840.1.113883.6.1" displayName="Cortisol [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260630"/><high value="20260630"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="5d7923f7-2f58-4f10-8cbb-bee3e626f251"/>
          <code code="2143-6" codeSystem="2.16.840.1.113883.6.1" displayName="Cortisol [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-66"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="13.1" unit="ug/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>Morning sample, drawn before 9 a.m.</text>
              <value xsi:type="IVL_PQ"><low value="5" unit="ug/dL"/><high value="23" unit="ug/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="4e64332f-686f-4fc3-aa88-a5684089a490"/>
      <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260630"/><high value="20260630"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="6ec9e268-c392-47cb-8418-a8d2111a0ac7"/>
          <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
          <text><reference value="#result-67"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260630"/>
          <value xsi:type="PQ" value="4" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-06-30; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well but tired; weight 72.4 kg; blood pressure 122/78, pulse 64, temperature 36.4 °C</td></tr><tr><td>Neck</td><td>Thyroid not enlarged or tender</td></tr><tr><td>Abdomen</td><td>Soft, non-tender; no mass</td></tr><tr><td>Extremities</td><td>No leg swelling; calf circumferences unchanged</td></tr><tr><td>Neurological</td><td>Pinprick slightly reduced over the toes only; ankle reflexes present with a slow relaxation phase; steady gait</td></tr><tr><td>Psychiatric</td><td>Alert and engaged</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Postmenopausal bleeding for three weeks, about eight years after her last period, in a woman of 60 who takes no hormone therapy: endometrial cancer must be excluded. Office endometrial biopsy taken today, transvaginal ultrasound this week, and gynecologic oncology review booked</td><td>resolved</td><td>confirmed</td>
    <td>N95.0</td><td>S — Synthetic presenting problem; no symptom of her real illness was made public. Superseded by the diagnosis at the gynecologic oncology consultation.</td>
  </tr>
  <tr ID="problem-2">
    <td>Endometrioid adenocarcinoma of the endometrium, FIGO grade 2, mismatch repair deficient (loss of MLH1 and PMS2 staining), p53 wild-type pattern, on office endometrial biopsy, with enlarged right pelvic and para-aortic lymph nodes on CT; surgical staging planned; synthetic modern detail linked to her publicly reported endometrial cancer</td><td>active</td><td>confirmed</td>
    <td>C54.1</td><td>S — Synthetic histology, molecular result and extent; her family gave endometrial cancer as the cause of death (D), and nothing more about it was made public.</td>
  </tr>
  <tr ID="problem-3">
    <td>Metastatic endometrioid carcinoma in the right external iliac sentinel lymph node (9 mm deposit) and a left para-aortic lymph node (14 mm deposit), with the other nodes removed negative: FIGO 2023 stage IIIC2ii</td><td>active</td><td>confirmed</td>
    <td>C77.8</td><td>S — Synthetic nodal disease found at surgical staging.</td>
  </tr>
  <tr ID="problem-4">
    <td>Chemotherapy-induced peripheral neuropathy from paclitaxel: tingling in the toes, grade 1 (sensory only, no effect on daily activities)</td><td>active</td><td>confirmed</td>
    <td>G62.0</td><td>S — Synthetic common effect of paclitaxel.</td>
  </tr>
  <tr ID="problem-5">
    <td>Immune-related primary hypothyroidism from dostarlimab: TSH 11.8 with a low free T4, tiredness and feeling cold (grade 2)</td><td>active</td><td>confirmed</td>
    <td>E03.2</td><td>S — Synthetic immune-related adverse event, among the most common with PD-1 inhibitors.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b42dc53d-d058-455e-9f4d-83ed45544f8b"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260105"/><high value="20260120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c96763e9-c991-42b6-91c0-16e501265378"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260105"/><high value="20260120"/></effectiveTime>
          <value xsi:type="CD" code="N95.0" codeSystem="2.16.840.1.113883.6.90" displayName="Postmenopausal bleeding"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="73bec413-d1e2-487c-bf2b-d38fdd2c96e0"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="38cc1af5-b25d-4031-8aa0-7d9065c9f36e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260120"/></effectiveTime>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="39e9f6e5-ccd6-4b98-b85f-cf6ce437cfe8"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260224"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="6b87f1a4-34c9-4a5d-a010-ba49eb3beba4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260224"/></effectiveTime>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="186a0158-b33b-4bc2-8981-69d02d38cc1a"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260428"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="938c171a-509e-4e15-8e0c-27d92ae23ff9"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260428"/></effectiveTime>
          <value xsi:type="CD" code="G62.0" codeSystem="2.16.840.1.113883.6.90" displayName="Drug-induced polyneuropathy"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="ca6af87c-e982-4669-8c44-eb89d21097e7"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260630"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="1e4ec5a7-823f-421a-92a2-1aa1f58b39db"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260630"/></effectiveTime>
          <value xsi:type="CD" code="E03.2" codeSystem="2.16.840.1.113883.6.90" displayName="Hypothyroidism due to medicaments and other exogenous substances"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Endometrioid endometrial cancer, stage IIIC2ii, MMRd, no evidence of disease after combination treatment (C54.1)</content>. No evidence of disease on CT, so radiation is not needed. Maintenance dostarlimab continues every six weeks for up to three years. Counts have recovered: hemoglobin 11.4 g/dL, neutrophils 2.8, platelets 228. Kidney and liver function and glucose are normal. Dr. Delacroix and she agreed today&apos;s plan. [S]<list><item>Dostarlimab 1000 mg today, then every six weeks.</item><item>Survivorship care plan given: examination with a pelvic examination every three months for two years; CT every six months for three years; no routine vaginal cytology and no CA-125.</item><item>Report vaginal bleeding, pelvic or abdominal pain, cough, weight loss or leg swelling.</item></list></item><item><content styleCode="Bold">Immune-related primary hypothyroidism, grade 2 (E03.2)</content>. TSH 11.8 with free T4 0.7, below range, and tiredness, feeling cold and a slower pulse: primary hypothyroidism from dostarlimab, the most common immune-related endocrine effect. Morning cortisol 13.1 is normal, so adrenal insufficiency is not the cause of her tiredness and thyroid replacement can start safely. Dostarlimab can continue with replacement. [S]<list><item>Levothyroxine 75 mcg daily before breakfast, starting today.</item><item>TSH and free T4 in six weeks, then with every dose.</item><item>Thyroid hormone will probably be needed long term.</item></list></item><item><content styleCode="Bold">Chemotherapy-induced peripheral neuropathy, grade 1 (G62.0)</content>. Stable after the last paclitaxel; expected to improve slowly. [S]<list><item>Review at each visit.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Imaging</td><td>Response imaging (CT of the chest, abdomen and pelvis)</td><td>At the end of combination treatment</td><td>Up to date</td><td>A week ago: no evidence of disease</td></tr><tr><td>Laboratory</td><td>Blood count with neutrophils and platelets</td><td>Before each cycle; at the end of treatment</td><td>Completed today</td><td>Hemoglobin 11.4 g/dL, white cells 4.9, neutrophils 2.8, platelets 228; recovered</td></tr><tr><td>Laboratory</td><td>Creatinine and estimated kidney function</td><td>Before each checkpoint inhibitor dose</td><td>Completed today</td><td>Creatinine 0.84 mg/dL, eGFR 80</td></tr><tr><td>Laboratory</td><td>Liver tests (paclitaxel and checkpoint inhibitor)</td><td>Baseline and before each checkpoint inhibitor dose</td><td>Completed today</td><td>ALT 22, AST 24 U/L, bilirubin 0.5 mg/dL</td></tr><tr><td>Laboratory</td><td>TSH and free T4 (immune-related thyroid disease)</td><td>Baseline and before each checkpoint inhibitor dose</td><td>Completed today</td><td>TSH 11.8 mIU/L and free T4 0.7 ng/dL: immune-related hypothyroidism; levothyroxine started</td></tr><tr><td>Laboratory</td><td>Glucose (immune-related diabetes)</td><td>Baseline and before each checkpoint inhibitor dose</td><td>Completed today</td><td>90 mg/dL</td></tr><tr><td>Laboratory</td><td>Morning cortisol (immune-related adrenal and pituitary disease)</td><td>Baseline and before each checkpoint inhibitor dose</td><td>Completed today</td><td>13.1 ug/dL, normal; drawn before 9 a.m. under the standing order</td></tr><tr><td>Laboratory</td><td>CA-125</td><td>Only if raised at diagnosis</td><td>Not indicated</td><td>Normal at diagnosis (28 U/mL)</td></tr><tr><td>Examination</td><td>Peripheral neuropathy: symptoms and examination</td><td>At each visit after taxane treatment</td><td>Completed today</td><td>Grade 1, stable</td></tr><tr><td>Examination</td><td>Lymphedema</td><td>Each visit after lymph node surgery</td><td>Completed today</td><td>No swelling</td></tr><tr><td>Examination</td><td>Immune-related adverse event symptoms (diarrhea, rash, cough, breathlessness, fatigue, headache)</td><td>Each visit on a checkpoint inhibitor</td><td>Completed today</td><td>Tiredness and cold intolerance, explained by hypothyroidism; no diarrhea, rash, cough or headache</td></tr><tr><td>Examination</td><td>Pelvic examination</td><td>Every three months for two years</td><td>Due</td><td>With gynecologic oncology in three months</td></tr><tr><td>Imaging</td><td>Surveillance CT of the chest, abdomen and pelvis</td><td>Every six months for three years for stage III disease</td><td>Due</td><td>Next in six months</td></tr><tr><td>Medication safety</td><td>Levothyroxine: timing and interactions</td><td>At the start</td><td>Completed today</td><td>Take on an empty stomach before breakfast, four hours apart from calcium or iron</td></tr><tr><td>Survey</td><td>Distress and depression screen (PHQ-9)</td><td>At diagnosis, each treatment phase, and when symptoms change</td><td>Completed today</td><td>PHQ-9 4</td></tr><tr><td>Self-management</td><td>Survivorship care plan</td><td>At the end of active treatment</td><td>Completed today</td><td>Written plan: visit schedule, symptoms of recurrence to report, lymphedema signs, weight and activity, blood pressure, lipid and glucose care, and screening for other cancers</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Endometrial tissue diagnosis and ultrasound within one week, and a gynecologic oncology plan within three weeks of presentation. Outcome by 2026-01-20: Biopsy at the first visit, ultrasound in two days, result in four days, CT in eight, consultation at two weeks [S]</item><item>Surgical staging within four weeks of diagnosis. Outcome by 2026-02-24: Minimally invasive hysterectomy with sentinel node mapping and para-aortic node removal two weeks after the consultation [S]</item><item>Six cycles of dostarlimab with carboplatin and paclitaxel every three weeks without a delay of more than one week. Outcome by 2026-06-30: Six cycles on schedule; CT shows no evidence of disease [S]</item><item>Lynch syndrome tumor screening completed and explained before treatment starts. Outcome by 2026-02-24: MLH1 promoter hypermethylation found: acquired, not inherited; genetic counseling done [S]</item><item>Immune-related adverse events found early: TSH, liver tests, glucose and cortisol checked on schedule. Outcome by 2026-06-30: Hypothyroidism found on a scheduled TSH and treated without stopping dostarlimab; one missed baseline cortisol recorded and corrected [S]</item><item>PHQ-9 below 10 throughout treatment, with support she chooses. Outcome by 2026-06-30: PHQ-9 between 4 and 6 [S]</item></list><paragraph>Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms (2026); Mirza MR, et al. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer (RUBY). N Engl J Med 2023;388(23):2145-2158 (PMID 36972026) (2023); JEMPERLI (dostarlimab-gxly) injection, prescribing information (2026); Salani R, et al. Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement. Gynecol Oncol 2026;204:109-117 (PMID 41308226) (2026); Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021;39(36):4073-4126 (PMID 34724392) (2021); Loprinzi CL, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol 2020;38(28):3325-3348 (2020); CMID: Clinical Monitoring Intelligence Database, endometrial cancer and hypothyroidism monographs (2026); Depression and Suicide Risk in Adults: Screening (2023)</paragraph><paragraph>Follow-up: Preventive visit in six weeks with TSH and free T4, on the day of the second maintenance dose. Gynecologic oncology examination in three months; CT in six months. Call for vaginal bleeding, pelvic pain, cough, diarrhea, rash or breathlessness. Next scheduled visit 2026-08-11: periodic adult preventive visit. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
